Moderna officer plans $5.9M stock sale in 2026

Rhea-AI Filing Summary

Moderna, Inc. (MRNA) reported that officer Stephen Hoge filed a notice under Rule 144 for a planned sale of 40,281 shares of common stock, expected on or after September 15, 2026, in connection with a stock option exercise, with Fidelity Brokerage Services LLC acting as broker.

The notice also lists Hoge’s prior Rule 144 sales of Moderna common stock over the past three months in three separate transactions.

Key Figures

Shares to be sold: 40,281 shares Aggregate market value of proposed sale: $5,883,709.01 Shares outstanding: 399,235,889 shares +3 more

6 metrics

Shares to be sold 40,281 shares Common stock proposed for sale under Rule 144 on or after September 15, 2026

Aggregate market value of proposed sale $5,883,709.01 Value reported for the 40,281 shares of common stock to be sold

Shares outstanding 399,235,889 shares Moderna common shares outstanding as referenced in the notice

Shares sold June 15, 2026 53,336 shares Common stock sold by Stephen Hoge with aggregate value $2,739,870.32

Shares sold July 15, 2026 53,336 shares Common stock sold by Stephen Hoge with aggregate value $3,605,513.60

Shares sold September 14, 2026 40,294 shares Common stock sold by Stephen Hoge with aggregate value $5,807,747.48

Key Terms

Rule 144, stock option exercise, aggregate market value, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

stock option exercise financial

"Common | 09/15/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"Common | Fidelity Brokerage Services LLC ... | 40281 | 5883709.01"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

attorney-in-fact regulatory

"as attorney-in-fact for Stephen Hoge"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Moderna (MRNA) disclose in this Form 144 filing?

The filing states that officer Stephen Hoge intends to sell 40,281 shares of Moderna common stock under Rule 144 in connection with a stock option exercise, with the proposed sale date listed as September 15, 2026.

How many Moderna (MRNA) shares are proposed to be sold by Stephen Hoge?

Stephen Hoge has notified an intended sale of 40,281 shares of Moderna common stock, to be sold through Fidelity Brokerage Services LLC under Rule 144, with a proposed sale date of September 15, 2026.

What is the aggregate market value of the Moderna (MRNA) shares in this planned Rule 144 sale?

The notice reports an aggregate market value of approximately $5,883,709.01 for the 40,281 shares of Moderna common stock proposed to be sold under Rule 144.

What prior Moderna (MRNA) stock sales by Stephen Hoge are disclosed in the last 3 months?

The filing lists three prior sales of Moderna common stock by Stephen Hoge: 53,336 shares on June 15, 2026, 53,336 shares on July 15, 2026, and 40,294 shares on September 14, 2026, each with reported aggregate sale values.

How many Moderna (MRNA) shares are reported as outstanding in this notice?

The notice reports that 399,235,889 shares of Moderna common stock were outstanding, providing context for the 40,281 shares proposed to be sold under Rule 144; this is a baseline figure, not the amount being offered.

Who is acting on behalf of Stephen Hoge in the Moderna (MRNA) Form 144?

The notice is signed by Gary Redman as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Stephen Hoge in connection with this Rule 144 sale notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 10:46 AM Accepted by SEC EDGAR 09/15/2026 - 10:46 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001760669
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Moderna, Inc.
SEC File Number	001-38753
Address of Issuer	325 BINNEY STREET CAMBRIDGE MASSACHUSETTS 02142
Phone	6177146500
Name of Person for Whose Account the Securities are To Be Sold	Hoge Stephen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	40281	5883709.01	399235889	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2026	Stock Option Exercise	Issuer			40281	09/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stephen Hoge 325 Binney Street Cambridge MA 02142	Common	06/15/2026	53336	2739870.32
Stephen Hoge 325 Binney Street Cambridge MA 02142	Common	07/15/2026	53336	3605513.60
Stephen Hoge 325 Binney Street Cambridge MA 02142	Common	09/14/2026	40294	5807747.48

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/15/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Stephen Hoge
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)